JY
LSTA icon

Jeff Yass’s Lisata Therapeutics LSTA Stock Holding History

Jeff Yass’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,600
Closed -$91K – 13142
2022
Q3 		$91K Buy
19,600
+16,320
+498% +$118K ﹤0.01% 11773
2022
Q2 		$26K Sell
3,280
-660
-17% -$5.43K ﹤0.01% 12283
2022
Q1 		$43K Buy
3,940
+2,220
+129% +$25.4K ﹤0.01% 12372
2021
Q4 		$22K Buy
1,720
+480
+39% +$7.41K ﹤0.01% 12810
2021
Q3 		$23K Sell
1,240
-8,300
-87% -$163K ﹤0.01% 12524
2021
Q2 		$230K Sell
9,540
-1,007
-10% -$23.9K ﹤0.01% 11297
2021
Q1 		$305K Buy
+10,547
New +$320K ﹤0.01% 10567
2020
Q4 		– Sell
-1,300
Closed -$35K – 11434
2020
Q3 		$35K Sell
1,300
-420
-24% -$13.3K ﹤0.01% 10291
2020
Q2 		$46K Buy
+1,720
New +$50.6K ﹤0.01% 9770
2019
Q4 		– Sell
-1,027
Closed -$39K – 10237
2019
Q3 		$39K Sell
1,027
-673
-40% -$26.2K ﹤0.01% 9846
2019
Q2 		$58K Sell
1,700
-267
-14% -$11.9K ﹤0.01% 9806
2019
Q1 		$107K Buy
+1,967
New +$129K ﹤0.01% 8219
2014
Q4 		– Sell
-143
Closed -$119K – 9884
2014
Q3 		$119K Sell
143
-334
-70% -$292K ﹤0.01% 9021
2014
Q2 		$467K Buy
477
+186
+64% +$181K ﹤0.01% 7600
2014
Q1 		$307K Buy
+291
New +$315K ﹤0.01% 7556

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Jeff Yass's LSTA Position: Q2 2026 in Review

Jeff Yass sold out of Lisata Therapeutics (LSTA) in Q2 2026, closing a stake of 11,604 shares — an estimated $58.1K sold.

Jeff Yass first reported a position in LSTA in Q4 2013 and held it in 23 quarters. The position peaked at $502K in Q2 2015. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Jeff Yass reported no remaining Lisata Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 11,604 Lisata Therapeutics shares in Q2 2026, an estimated $58.1K.
  • Jeff Yass first reported a position in Lisata Therapeutics in Q4 2013 and held it in 23 quarters.
  • Jeff Yass's Lisata Therapeutics position peaked at $502K in Q2 2015.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.